An Assessment of Paediatricians' Knowledge and Perspectives of Duchenne Muscular Dystrophy in Oman. [PDF]
Al Jabri Z +4 more
europepmc +1 more source
Vamorolone for Duchenne Muscular Dystrophy: A Cross-Trial Efficacy Comparison With Classic Corticosteroids From the FOR-DMD Trial. [PDF]
Clemens PR +11 more
europepmc +1 more source
Metabolic Complications and Ultrasound-Detected Liver Abnormalities in Paediatric Patients With Duchenne Muscular Dystrophy. [PDF]
Śledzińska K +14 more
europepmc +1 more source
FDA-approved antisense oligonucleotide therapies for duchenne muscular dystrophy: current status and future outlook. [PDF]
Moriyama H, Moriyama S, Yokota T.
europepmc +1 more source
Gene Editing Strategies for Duchenne Muscular Dystrophy: From Molecular Mechanisms to Clinical Translation. [PDF]
Siddika A +5 more
europepmc +1 more source
Correction: Impact of C4BPA on Muscle progenitor cell differentiation: insights for Duchenne muscular dystrophy treatment. [PDF]
Fernández-Simón E +12 more
europepmc +1 more source
Genetic, Clinical, and Management Characteristics of Duchenne Muscular Dystrophy in Saudi Arabia. [PDF]
AlSaman AS +12 more
europepmc +1 more source
Assessing movement quality in individuals with Duchenne muscular dystrophy utilizing accelerometry: Comparisons with healthy controls. [PDF]
Joy N +15 more
europepmc +1 more source
Awareness of Duchenne muscular dystrophy among medical staff in China: a multicenter cross-sectional survey. [PDF]
Zhai C +8 more
europepmc +1 more source
Correction: Investigating the role of EGFR signalling in muscle dystrophies: implications for Duchenne muscular dystrophy. [PDF]
Fernández-Simón E +9 more
europepmc +1 more source

